Summit Therapeutics Stock Surges After AstraZeneca Reveals $2 Billion Investment — Barrons.com
By Evie LiuSummit Therapeutics stock jumped about 15% in after-hours trading Monday after pharmaceutical giant AstraZeneca announced a $2 billion investment in the cancer-drug developer, alongside an agreement to collaborate on experimental cancer treatments.AstraZeneca will purchase convertible pr…